RECURSION LONDON LTD
12648333Research and experimental development on biotechnology
RECURSION LONDON LTD
Research and experimental development on biotechnology
Previous Company Names
Contact & Details
Contact
Registered Address
3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT United Kingdom
Full company profile for RECURSION LONDON LTD (12648333), an active life sciences and medical technology company based in Altrincham, United Kingdom. Incorporated 5 Jun 2020. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Balance Sheet & P&L (2020–2024)
Cash in Bank
£653.33k
Net Assets
£188.02k
Total Liabilities
£3.47M
Turnover
£4.87M
Employees
11
Debt Ratio
95%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 31 Dec Year End | 2023 31 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
No fundraising or grants recorded
Investors (0)
No investor information available
Officers
Officers
| Status | |||||||
|---|---|---|---|---|---|---|---|
No officers found | |||||||
No officers found
See all 12 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (1)
Recursion Pharmaceuticals, Inc.
United States Of America
- Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors
Group Structure
Group Structure
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 19 May 2026 | Officers | Termination of Christopher Cory Gibson as director on 15 May 2026 | |
| 19 May 2026 | Officers | Appointment of Andrew John Overton as director on 15 May 2026 | |
| 19 May 2026 | Officers | Appointment of Kyle Benjamin Nelson as director on 15 May 2026 | |
| 19 May 2026 | Officers | Termination of Nathan Ben Hatfield as director on 15 May 2026 | |
| 2 Jan 2026 | Accounts | Annual accounts made up to 31 Dec 2024 |
Termination of Christopher Cory Gibson as director on 15 May 2026
Appointment of Andrew John Overton as director on 15 May 2026
Appointment of Kyle Benjamin Nelson as director on 15 May 2026
Termination of Nathan Ben Hatfield as director on 15 May 2026
Annual accounts made up to 31 Dec 2024
Recent Activity
Latest Activity
Termination of Christopher Cory Gibson as director on 15 May 2026
1 months ago on 19 May 2026
Appointment of Andrew John Overton as director on 15 May 2026
1 months ago on 19 May 2026
Appointment of Kyle Benjamin Nelson as director on 15 May 2026
1 months ago on 19 May 2026
Termination of Nathan Ben Hatfield as director on 15 May 2026
1 months ago on 19 May 2026
Annual accounts made up to 31 Dec 2024
5 months ago on 2 Jan 2026